NALADOR 500 micrograms, lyophilizate for parenteral use bottle, 2 ml
Active ingredients: Sulprostone
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Lyophilizate for parenteral usebottle, 2 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NALADOR 500 microgrammes, lyophilisat pour usage parentéral
- Pharmaceutical form
- lyophilisat pour usage parentéral
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre jaune(brun) de 2 ml
- Marketing authorisation holder
- TEOFARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Oct 2021
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61722693CIP75507961CIP133400955079613Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SULPROSTONElyophilisat | 0,500 mg · une ampoule ou un flacon de lyophilisat | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.